Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study.
Alcaraz A, González-López R, Morote J, de la Piedra C, Meseguer C, Esteban E, Climent M, González-Gragera B, Alvarez-Ossorio JL, Chirivella I, Mellado B, Lara PC, Vázquez F, Contreras JA, Carles J, Murias A, Calderero V, Comet-Batlle J, González-Del Alba A, León-Mateos L, Mañas A, Segarra J, Lassa A, González-Enguita C, Méndez MJ, Samper P, Unda M, Mahillo-Fernández I, Bellmunt J; TUGAMO GROUP. Alcaraz A, et al. Among authors: manas a. Br J Cancer. 2013 Jul 9;109(1):121-30. doi: 10.1038/bjc.2013.272. Epub 2013 Jun 25. Br J Cancer. 2013. PMID: 23799855 Free PMC article.
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study.
de la Piedra C, Alcaraz A, Bellmunt J, Meseguer C, Gómez-Caamano A, Ribal MJ, Vázquez F, Anido U, Samper P, Esteban E, Álvarez-Ossorio JL, Lara PC, San José LA, Contreras JA, del Alba AG, González-Gragera B, Tabernero AJ, González-Enguita C, Fernández JM, García-Escudero A, Gómez-Veiga F, Méndez MJ, Segarra J, Virizuela JA, Carles J, Lassa A, Calderero V, Constela M, Delgado D, Mañas A, Murias A, Reynes G, Rodriguez B, Rubio G, Sánchez E, Unda M, Solsona E, Martínez-Javaloyas JM, Comet-Batlle J, Quicios C, Martín-Fernández M, Mahillo-Fernández I, Morote J. de la Piedra C, et al. Among authors: manas a. Br J Cancer. 2013 Jun 25;108(12):2565-72. doi: 10.1038/bjc.2013.270. Epub 2013 May 30. Br J Cancer. 2013. PMID: 23722472 Free PMC article. Clinical Trial.
Randomised study of single dose (8 Gy vs. 6 Gy) of analgesic radiotherapy plus zoledronic acid in patients with bone metastases.
Mañas A, Casas F, Ciria JP, López C, Sáez J, Palacios A, de las Heras M, Porto C, Sánchez E, Martín C, Esco R, Veiras C, Martínez JC, Márquez M, Ramos A, Calvo F, Fuertes J, Andreu FJ, Contreras J, Pérez L, Romero J, Vayreda J, Victoria C. Mañas A, et al. Clin Transl Oncol. 2008 May;10(5):281-7. doi: 10.1007/s12094-008-0198-5. Clin Transl Oncol. 2008. PMID: 18490245 Clinical Trial.
The white book of radiation oncology in Spain.
Herruzo I, Romero J, Palacios A, Mañas A, Samper P, Bayo E, Guedea F; Libro Blanco de Oncología Radioterápica. Herruzo I, et al. Among authors: manas a. Clin Transl Oncol. 2011 Jun;13(6):385-95. doi: 10.1007/s12094-011-0672-3. Clin Transl Oncol. 2011. PMID: 21680299
Prevalence of neuropathic pain in radiotherapy oncology units.
Mañas A, Monroy JL, Ramos AA, Cano C, López-Gómez V, Masramón X, Pérez M; TENOR collaborative study group. Mañas A, et al. Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):511-20. doi: 10.1016/j.ijrobp.2010.05.047. Epub 2010 Sep 9. Int J Radiat Oncol Biol Phys. 2011. PMID: 20832183
Epidemiology and prevalence of oropharyngeal candidiasis in Spanish patients with head and neck tumors undergoing radiotherapy treatment alone or in combination with chemotherapy.
Mañas A, Cerezo L, de la Torre A, García M, Alburquerque H, Ludeña B, Ruiz A, Pérez A, Escribano A, Manso A, Glaria LA; Grupo de Investigación Clínica en Oncología Radioterápica (GICOR). Mañas A, et al. Clin Transl Oncol. 2012 Oct;14(10):740-6. doi: 10.1007/s12094-012-0861-8. Epub 2012 Sep 8. Clin Transl Oncol. 2012. PMID: 22960994
Should the prescription of oral anticancer drugs be restricted?
Ramos A, Torrecilla JL, Lara P, Herruzo I, Contreras J, Mañas A, Guedea F; board of directors of the Spanish Society of Radiation Oncology (SEOR). Ramos A, et al. Among authors: manas a. Rep Pract Oncol Radiother. 2012 Jul 19;17(4):187-9. doi: 10.1016/j.rpor.2012.07.003. eCollection 2012. Rep Pract Oncol Radiother. 2012. PMID: 24377022 Free PMC article. No abstract available.
144 results